Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-24-007192
Filing Date
2024-10-17
Accepted
2024-10-17 15:15:38
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 TO QUARTERLY REPORT cardiff_i10qa1-33124.htm   iXBRL 10-Q/A 1317033
2 CERTIFICATION cardiff_10qa1-ex3101.htm EX-31.1 12767
3 CERTIFICATION cardiff_10qa1-ex3102.htm EX-31.2 12696
4 CERTIFICATION cardiff_10qa1-ex3201.htm EX-32.1 4492
5 CERTIFICATION cardiff_10qa1-ex3202.htm EX-32.2 4497
  Complete submission text file 0001683168-24-007192.txt   7243047

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdif-20240331.xsd EX-101.SCH 57360
7 XBRL CALCULATION FILE cdif-20240331_cal.xml EX-101.CAL 65219
8 XBRL DEFINITION FILE cdif-20240331_def.xml EX-101.DEF 204374
9 XBRL LABEL FILE cdif-20240331_lab.xml EX-101.LAB 392405
10 XBRL PRESENTATION FILE cdif-20240331_pre.xml EX-101.PRE 336997
84 EXTRACTED XBRL INSTANCE DOCUMENT cardiff_i10qa1-33124_htm.xml XML 1222883
Mailing Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169
Business Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169 844-628-2100
Cardiff Lexington Corp (Filer) CIK: 0000811222 (see all company filings)

EIN.: 841044583 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-49709 | Film No.: 241377413
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 03 Life Sciences)